首页>
外国专利>
Use of rasburicase for producing a medicament for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events
Use of rasburicase for producing a medicament for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events
展开▼
机译:葡萄酰胺酶在制备用于治疗或预防由缺血或再灌注事件引起的心脏疾病或间接后遗症的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of a urate oxidase, preferably recombinant urate oxidase, for example rasburicase, for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events, for example during and after cardiac surgery like CABG (coronary artery bypass graft), PCI (percutaneous coronary intervention), transplantation, post myocardial infarction and for the treatment or prophylaxis of coronary artery disease or heart failure, for example congestive heart failure.
展开▼